We also analyzed the effects of SCAP deletion in another NASH-HCC mouse model, the choline-deficient, l-amino acid–defined, high-fat-diet (CDAHFD) model (25). This evidence concerns the gene SCAP and metabolic dysfunction-associated steatohepatitis.